Publications

  1. Chandrashekaran S, Escalante P, Kennedy CC. Mycobacterium abscessus disease in lung transplant recipients: Diagnosis and management Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.2017;
  2. Molassiotis A, Smith JA, Mazzone P, Irwin RS, CHEST Expert Cough Panel. Symptomatic Treatment of Cough Among Adult Patients With Lung Cancer: CHEST Guideline and Expert Panel Report Chest.2017;151:(4)861-874.
  3. Boulet LP, Turmel J, Irwin RS, CHEST. Cough in the Athlete: CHEST Guideline and Expert Panel Report Chest.2017;151:(2)441-454.
  4. Meier E, Pennington K, Gallo de Moraes A, Escalante P. Characteristics of Mycobacterium avium complex (MAC) pulmonary disease in previously treated lung cancer patients. Respir Med Case Rep. 2017; 22:70-73.
    View PubMed
  5. Pennington K, Sasieta HC, Ramos GP, Erskine CL, Van Keulen VP, Peikert T, Escalante P. Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis. Clin Med Insights Case Rep. 2017; 10:1179547617724776 Epub 2017 Aug 24
    View PubMed
  6. Kahrilas PJ, Altman KW, Chang AB, Field SK, Harding SM, Lane AP, Lim K, McGarvey L, Smith J, Irwin RS, CHEST Expert Cough Panel. Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report. Chest. 2016 Dec; 150 (6):1341-1360 Epub 2016 Sept 07
    View PubMed
  7. Tarlo SM, Altman KW, Oppenheimer J, Lim K, Vertigan A, Prezant D, Irwin RS, CHEST Expert Cough Panel. Occupational and Environmental Contributions to Chronic Cough in Adults: Chest Expert Panel Report. Chest. 2016 Oct; 150: (4)894-907.
    View PubMed
  8. Wilson JW, Garay-Ramos J, Castillo F, Castellanos EF, Escalante P. Tuberculosis Patient and Family Education through Videography in El Salvador. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.April 2016;4:14-20.
  9. Pennington K, Van Zyl M, Escalante P. Citrobacter koseri Pneumonia As Initial Presentation of Underlying Pulmonary Adenocarcinoma. Clin Med Insights Case Rep. 2016; 9:87-89.
    View PubMed
  10. Clain JM, Escalante P. Novel treatments for drug-resistant tuberculosis Clinical Medicine Insights: Therapeutics. 2016; 8:21-8.
  11. Wilson JW, Ramos JG, Castillo F, Castellanos EF, Escalante P. Tuberculosis patient and family education through videography in El Salvador Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2016; 4:14-20.
  12. Escalante P, Peikert T, Van Keulen VP, Erskine CL, Bornhorst CL, Andrist BR, McCoy K, Pease LR, Abraham RS, Knutson KL, Kita H, Schrum AG, Limper AH. Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification. Am J Respir Crit Care Med. 2015 Sep 1; 192: (5)605-17.
    View PubMed
  13. Vertigan AE, Murad MH, Pringsheim T, Feinstein A, Chang AB, Newcombe PA, Rubin BK, McGarvey LP, Weir K, Altman KW, Weinberger M, Irwin RS, CHEST Expert Cough Panel. Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel Report. Chest. 2015 Jul; 148: (1)24-31.
    View PubMed
  14. French CT, Diekemper RL, Irwin RS, CHEST Expert Cough Panel. Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel Report. Chest. 2015 Jul; 148: (1)32-54.
    View PubMed
  15. Villarino ME, Scott NA, Weis SE, Weiner M, Conde MB, Jones B, Nachman S, Oliveira R, Moro RN, Shang N, Goldberg SV, Sterling TR, International Maternal Pediatric and Adolescents AIDS Clinical Trials Group//Tuberculosis Trials Consortium. Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid. JAMA Pediatr. 2015 Mar; 169: (3)247-55.
    View PubMed
  16. Boulet LP, Coeytaux RR, McCrory DC, French CT, Chang AB, Birring SS, Smith J, Diekemper RL, Rubin B, Irwin RS, CHEST Expert Cough Panel. Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report. Chest. 2015 Mar; 147: (3)804-14.
    View PubMed
  17. Escalante P, Kooda KJ, Khan R, Aye SS, Christianakis S, Arkfeld DG, Ehresmann GR, Kort JJ, Jones BE. Diagnosis of latent tuberculosis infection with T-SPOT((R)).TB in a predominantly immigrant population with rheumatologic disorders. Lung. 2015 Feb; 193 (1):3-11 Epub 2014 Oct 16
    View PubMed
  18. Canning BJ, Chang AB, Bolser DC, Smith JA, Mazzone SB, McGarvey L, CHEST Expert Cough Panel. Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report. Chest. 2014 Dec; 146: (6)1633-48.
    View PubMed
  19. Lewis SZ, Diekemper RL, French CT, Gold PM, Irwin RS, CHEST Expert Cough Panel. Methodologies for the development of the management of cough: CHEST guideline and expert panel report. Chest. 2014 Nov; 146: (5)1395-402.
    View PubMed
  20. Irwin RS, French CT, Lewis SZ, Diekemper RL, Gold PM, CHEST Expert Cough Panel. Overview of the management of cough: CHEST Guideline and Expert Panel Report. Chest. 2014 Oct; 146: (4)885-9.
    View PubMed
  21. Birkenkamp KE, Lauzardo M, Mangura BT, Brito MO, Griffith DT, Seaworth BJ, Escalante P. Diagnosis and Management of Latent Tuberculosis and Tuberculosis in Candidates for TNF-alpha Antagonist Therapy: An Expert Survey J of Mycobac Dis.2014, Oct;4(5):171.
  22. Arias-Guillen M, Riestra S, de Francisco R, Palacios JJ, Belda J, Escalante P, Perez-Martinez I, Molinos LM, Garcia-Clemente M, Pando-Sandoval A, Rodrigo L, Prieto A, Martinez-Camblor P, Losada A, Casan P. T-cell profiling and the immunodiagnosis of latent tuberculosis infection in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2014 Feb; 20(2):329-38.
    View PubMed
  23. Escalante P, McKean-Cowdin R, Ramaswamy SV, Williams-Bouyer N, Teeter LD, Jones BE, Graviss EA. Can mycobacterial katG genetic changes in isoniazid-resistant tuberculosis influence human disease features? Int J Tuberc Lung Dis. 2013 May; 17(5):644-51. Epub 2013 Mar 01.
    View PubMed
  24. Sattah MV, Aye SS, Azen C, Kort JJ, Escalante P, Jones BE. Interferon-gamma release assay T-SPOT(R).TB and HIV-related tuberculosis [Correspondence]. Int J Tuberc Lung Dis. 2012 Feb 01; 16 (2):281-282
    View PubMed
  25. Haydour Q, Wells MA, McCoy SS, Nelsen E, Escalante P, Matteson EL. Anti-synthetase syndrome presenting as cryptogenic organizing pneumonia. Respir Med Case Rep. 2012; 6:13-5.
    View PubMed
  26. Escalante P. In the clinic. Tuberculosis. Ann Intern Med. 2009 Jun 2; 150(11):ITC61-614; quiz ITV616.
    View PubMed
  27. Escalante P. Mycobacterial infections in solid organ transplantation. Curr Opin Organ Transplant. 2007; 12:585-90.
  28. El Sahly HM, Wright JA, Soini H, Bui TT, Williams-Bouyer N, Escalante P, Musser JM, Graviss EA. Recurrent tuberculosis in Houston, Texas: a population-based study. Int J Tuberc Lung Dis. 2004 Mar; 8(3):333-40.
    View PubMed
  29. Slotar D, Escalante P, Jones BE. Pulmonary manifestations of HIV/AIDS in the tropics. Clin Chest Med. 2002 Jun; 23(2):355-67.
    View PubMed
  30. Escalante P, Graviss EA, Griffith DE, Musser JM, Awe RJ. Treatment of isoniazid-resistant tuberculosis in southeastern Texas. Chest. 2001 Jun; 119(6):1730-6.
    View PubMed
  31. Escalante P, Ramaswamy S, Sanabria H, Soini H, Pan X, Valiente-Castillo O, Musser JM. Genotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from Peru. Tuber Lung Dis. 1998; 79(2):111-8.
    View PubMed
  32. Sreevatsan S, Escalante P, Pan X, Gillies DA 2nd, Siddiqui S, Khalaf CN, Kreiswirth BN, Bifani P, Adams LG, Ficht T, Perumaalla VS, Cave MD, van Embden JD, Musser JM. Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis. J Clin Microbiol. 1996 Aug; 34(8):2007-10.
    View PubMed